PUBLIC COMPANY
save$ENSCEnsysce Biosciences, Inc.
$ENSCLa Jolla, CA, USupdated 18d ago
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
- phase3PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
- phase2Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
- phase1Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
- phase1Evaluation of Oral PF614 Relative to OxyContin (PF614-102)
- phase1Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)
- phase1A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
- phase1A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that